News

The trial was sponsored by the National Cancer Institute (NCI), under a cooperative R&D agreement between NCI and Genentech, and conducted by a network of researchers led by

The phase II clinical trial of GCAN 101 will commence at the medical center and include up to 30 patients suffering from metastatic melanoma, metastatic prostate or colon

Under the agreement, Repligen will receive funding for a phase I clinical trial to assess the oral bioavailability of the company’s proprietary formulation of uridine. This phase I

This is the first report in which patients with type-1 diabetes, using glargine insulin (Sanofi-Aventis’ Lantus) as their baseline therapy, have been maintained with optimal control using a

The phase I clinical trial is the first of a planned series of studies examining the safety and pharmacokinetics of PBT2 in normal human volunteers. PBT2 is the

Under the agreement, Benchmark will manufacture Probactrix for BioBalance’s proposed clinical trials in the US once BioBalance receives FDA clearance to proceed with those trials. The product will

The company’s announcement is based on the outcome of a meeting with the FDA on March 11. La Jolla plans to continue the ongoing clinical benefit trial and

The class action lawsuit was filed against American Pharmaceutical Partners, certain of its officers and American BioScience, the company’s strategic partner for Abraxane, while a related derivative lawsuit

Ketoprofen is a non-steroidal anti-inflammatory drug (NSAID) generally used for the treatment of inflammation and pain and available in the US only in oral form. Under the terms